HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

2nd Edition of International Heart Congress

June 20-22,2024 | Hybrid Event

June 20 -22, 2024 | Paris, France

Heart Congress 2024

 Michael E Merhige, Speaker at Cardiovascular Conference
Keynote Presentation (In-Person)
Michael E Merhige, State University of NY at Buffalo, United States

Background: External Counter Pulsation (ECP) is an FDA approved, noninvasive, treatment for patients with refractory angina, who are not candidates for low-risk interventional revascularization, such as those with chronic total coronary occlusion (CTO). ECP uses sequentially infl [....] » Read More

Yong Xiao Wang, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Yong Xiao Wang, Albany Medical Center, United States

Pulmonary hypertension (PH) is a common and devastating lung disease. The current primary medications for this disease are to use non-specific vasodilators, but patients do not always respond well to non-specific vasodilators. Voltage-dependent potassium channels and store-operat [....] » Read More

Naranjan Dhalla, Speaker at Heart Conferences
Keynote Presentation (In-Person)
Naranjan Dhalla, St. Boniface Hospital Albrechtsen Research Centre, Canada

Although sudden cardiac death is considered to be a major mode of death in patients with heart failure, no satisfactory medical therapy is available for its prevention. Since over activation of sympathetic nervous system is invariably seen in subjects with high risk for sudden ca [....] » Read More

 Ahdy W Helmy, Speaker at Heart Conferences
Keynote Presentation (In-Person)
Ahdy W Helmy, Indiana University School of Medicine, United States

Metabolic Dysfunction and Metabolic Syndrome birthed with visceral adiposity, and Insulin resistance has wide spread implications. From a bed of inflammation at the visceral adipose tissue core, RAAS activation and constricted vascular micro-perfusion. To hyperinsulinemia and vol [....] » Read More

Sergey Suchkov, Speaker at Cardiovascular Conference
Keynote Presentation (In-Person)
Sergey Suchkov, The Russian University for Medicine & The Russian Academy of Natural Sciences, Russian Federation

A new systems approach to diseased states and wellness result in a new branch in the healthcare ser-vices, namely Personalized and Precision Medicine (PPM). To achieve the implementation of PPM concept, it is necessary to create a fundamentally new strategy based upon the re [....] » Read More

Elizabeth C Ghandakly, Speaker at Heart Conferences
Oral Presentation (In-Person)
Elizabeth C Ghandakly, Cleveland Clinic Foundation, United States

Recommendations for the primary prevention of cardiovascular disease (CVD) vary by global region. This variability occurs by nature of different practice guidelines being put forth by separate regional cardiology societies, such as The American College of Cardiology/American Hear [....] » Read More

Daniel A Lichtenstein, Speaker at Heart Conferences
Oral Presentation (In-Person)
Daniel A Lichtenstein, Ambroise Pare Hospital, France

Critical ultrasound was defined in our 1991 publication: “ultrasound for the critically ill, by the critical care physician, whole body ultrasound”. This definition, considering the lung, provides a new definition of ultrasound, now a clinical tool. The BLUE-prot [....] » Read More

Lusine Harutyunyan, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Lusine Harutyunyan, Adventist Health, United States

Importance on multidisciplinary approach to cardiovascular patients- specifically ASCVD and CHF groups. Financial and socioeconomic burden of cardiovascular disease and ways to improve patient outcomes and patient satisfaction. Will discuss ways to standardize medical care. ACC/A [....] » Read More

Cristina Milagre Quadros Borges, Speaker at Heart Conferences
Oral Presentation (In-Person)
Cristina Milagre Quadros Borges, hcor- Hospital do Coracao de Sao Paulo, Brazil

Smoking is considered a chronic disease, caused by chemical dependence of nicotine. This is highly addicting, it in the brain system, it  infuences our emotions increases the feeling of pleasure/humor and reduces the anxiety. In a planet with about 8 billion people, around 1 [....] » Read More

Prabode Weebadde, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Prabode Weebadde, Purdue University, United States

In the U.S., every year, about 800,000 people die due to cardiovascular diseases (CVD) or diseases related to the heart and blood vessels. Of those 800,000, 650,000 deaths were related to the heart, and 150,000 were related to blood vessels. To put it in another perspective, ever [....] » Read More

Sergey Suchkov, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Sergey Suchkov, The Russian University for Medicine & The Russian Academy of Natural Sciences, Russian Federation

Catalytic Abs (catAbs) are multivalent immunoglobulins (Igs) with a capacity to hydrolyze the antigenic (Ag) substrate. In this sense, proteolytic Abs (Ab-proteases) represent Abs to provide proteolytic effects. Autoimmune myocarditis (AIM) can be defined as the autoimmune i [....] » Read More

Xin Li, Speaker at Heart Conferences
Oral Presentation (In-Person)
Xin Li, Chinese PLA General Hospital-Sixth Medical Center, China

Objective: This article is in purpose of developing a multi-indicator combined diagnostic model of resting myocardial contrast echocardiography (MCE) to qualify myocardial perfusion dysfunction in coronary heart disease (CHD). Methods: We performed resting MCE and st [....] » Read More

Asma Ayadi, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Asma Ayadi, Tunisian Center for Nuclear Sciences and Technology, Tunisia

Arterial stiffness has emerged as a prominent marker of risk for cardiovascular disease. Few studies are interested in predicting symptomatic or asymptomatic arterial stiffness from hemodynamics and biomechanics parameters. Machine learning models can be used as an intelligent to [....] » Read More

T Rajini Samuel, Speaker at Cardiovascular Diseases Events
Oral Presentation (In-Person)
T Rajini Samuel, Shri Sathya Sai Medical College and Research Institute Sri Balaji Vidyapeeth, India

Introduction: Electrocardiogram (ECG) has offered immense clinical value for more than a century yet its interpretation remains an arduous task and ECG phobia  develops in some of the junior doctors and staff nurses often seeking the help of medical experts in that field. Ei [....] » Read More

Merab Beraia, Speaker at Heart Conferences
Oral Presentation (In-Person)
Merab Beraia, Tbilisi State University, Georgia

At the beginning of blood flow, red blood cells (RBCs) align in the central plane of the vessels. In capillaries, RBCs change from a biconcave disk to a parachute shape and as blood moves from the arterial to the venous end, hemoglobin in erythrocytes alters magnetic susceptibili [....] » Read More

Wael Shamsi Basha, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Wael Shamsi Basha, Istanbul Medipol University, Turkey

Infants with ductal-dependent pulmonary blood flow conditions pose unique challenges in surgical management. This study aims to investigate personalized treatment modalities, including computer-aided anatomical modeling and hemodynamic analysis, to optimize surgical planning and [....] » Read More

Ylber Jani, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Ylber Jani, Luarasi University Tirana Ai, Macedonia, The Former Yugoslav Republic of

Background: Approximately 50% of patients undergoing cardioversion usually present with recurrence of Atrial Fibrillation(AF) within 3–6?months of cardioversion despite ongoing antiarrhythmic treatment(AAD). Inflammation have been involved in the pathogenesis of both metabo [....] » Read More

Vivek Vaibhav, Speaker at Heart Conferences
Poster Presentation (In-Person)
Vivek Vaibhav, Metro Heart Hospital, India

Dilated cardiomyopathy (DCM) is a myocardial disease characterised by ventricular dilatation and global myocardial dysfunction (ejection fraction < 40%). Patients usually present with symptoms of biventricular failure, e.g. fatigue, dyspnoea, orthopnoea, ankle oedema A [....] » Read More

Thomas J Webster, Speaker at Heart Conferences
Keynote Presentation (In-Person)
Thomas J Webster, Interstellar Therapeutics, United States

Nanomedicine has already provided dozens of FDA approved products improving the lives of billions. Most notably, nanomaterials have been used to develop vaccines for COVID, improved spinal implants, anti-infection materials without using antibiotics, and numerous drug delivery ve [....] » Read More

Miroslav Radenkovic, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Miroslav Radenkovic, University of Belgrade, Serbia

Heart failure is a serious clinical syndrome with symptoms and signs provoked by a structural and functional cardiac abnormality, and coupled with elevated natriuretic peptide levels and evident pulmonary or systemic congestion. Regardless of outstanding improvements in the manag [....] » Read More

Susy Kotit, Speaker at Heart Conferences
Oral Presentation (In-Person)
Susy Kotit, Aswan Heart Centre, Egypt

During the presentation, the epidemiology and background of Rheumatic Heart Disease (RHD), with attention to statistics, global burden, and consequences will shortly be presented, followed by data on the resurgence of the disease in areas where it was previously eradicated.  [....] » Read More

Moacyr Nobre, Speaker at Heart Conferences
Oral Presentation (In-Person)
Moacyr Nobre, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), Brazil

Introduction: The effectiveness of the treatment of chronic diseases depends on the participation of the patient, influenced by different sociocultural factors, which are not fully recognized by the treatment routine. Objective: To search for some of these factors that hinder o [....] » Read More

Ajay Anil Bagalkot, Speaker at Cardiovascular Diseases Events
Oral Presentation (In-Person)
Ajay Anil Bagalkot, Aarupadai Veedu Medical College and Hospital, India

MI with non-obstructive coronary arteries (MINOCA) is precipitated secondary to a group of vascular or myocardial disorders. MINOCA occurs in 5–15% of patients presenting with acute ST-segment elevation MI or non-ST segment elevation MI and prognosis is impai [....] » Read More

Motahareh Ghodrati, Speaker at Heart Conferences
Oral Presentation (In-Person)
Motahareh Ghodrati, Qom University of Medical Sciences, Iran (Islamic Republic of)

Many improvements have been made for the CPB device since the early 1950s. The design and construction of oxygenators is based on three basic components: the mechanism for blood circulation, the method of gas exchange of oxygen and carbon dioxide, and the mechanism for temperatur [....] » Read More

Jamuna Rani Ayyalu, Speaker at Heart Conferences
Oral Presentation (In-Person)
Jamuna Rani Ayyalu, Sree Balaji Medical College And Hospitals, India

Management of stress by yogic practices like Surya Namaskar, Pranayama and Meditation. Medical education includes the strenuous course load and hectic schedule, most students have a lack of time to take care of health and relaxation techniques. Yoga is gaining prominence in impro [....] » Read More

Yanmin xu, Speaker at Cardiovascular Conference
Poster Presentation (In-Person)
Yanmin xu, Tian Jin Medical University, China

Background: To compare the effect of sacubitril/valsartan with benalapril on left ventricular remodeling in patients with acute myocardial infarction. Materials and Methods: 85 patients with acute ST segment elevation myocardial infarction who were treated with PCI in the Seco [....] » Read More

Jahanara Arzu, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Jahanara Arzu, Bangabandhu Sheikh Mujib Medical University, Bangladesh

Acute heart failure (AHF) is a major cause of morbidity and mortality worldwide. Although this is a common cause of dyspnoea, its diagnosis still represents a challenge. Lung ultrasound (LUS) is an emerging point-of-care diagnostic tool. Objective: The aim of the study was to ass [....] » Read More

Narges Mazloomi, Speaker at Heart Conferences
Poster Presentation (In-Person)
Narges Mazloomi, Mazandaran University of Medical Sciences, Iran (Islamic Republic of)

Introduction: The use of enzymes for hydrolysis of protein sources is one of the common methods in the food processing. A hydrolysed protein is a complex mixture of peptides and amino acids that are obtained from hydrolysis by various enzymes, acids or alkali. These hydrolysed pr [....] » Read More

Fatih Mehmet Ucar, Speaker at Heart Conferences
Poster Presentation (In-Person)
Fatih Mehmet Ucar, Demiroglu Bilim University Hospital, Turkey

Background: The number of pacemakers and defibrillators implanted in worldwide continues to increase.Subclavian vein stenosis/occlusion following transvenous cardiac device placement is a known complication of the procedure.Central venous spasm during pacemaker implantation is un [....] » Read More

Roger H Coletti, Speaker at Cardiovascular Diseases Events
Keynote Presentation (Virtual)
Roger H Coletti, Interventional Health, PA, United States

Throughout the body blood flow is regulated by vascular tone secondary to local or neurologic control. However, in the musculoskeletal system, the effects of muscular contraction can lead to augmentation of restriction of local blood flow. While repetitive muscle contraction incr [....] » Read More

Pedro A Jose, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Pedro A Jose, The George Washington University of School of Medicine & Health Sciences, United States

Globally, hypertension is the number one risk factor for death, affecting more than 1 billion people. Hypertension is the result of the interactions among genetics, epigenetics, environment, and lifestyle. The long-term regulation of blood pressure (BP) rests on renal and non-ren [....] » Read More

Syed Raza, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Syed Raza, Awali Hospital, Bahrain

Dyslipidaemia comprises  of abnormal lipid components  and  refers mainly to  increased levels of  LDL, non HDL particles and triglycerides while  decreased  levels of HDL Dyslipidaemia is a  common and independent  modifiable risk fac [....] » Read More

Mekhman N Mamedov, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation

WHO considers diabetes mellitus (DM) to be a pandemic that has spread throughout the world. In some countries, this epidemic reaches >8% of the adult population, and in 20 years the frequency is expected to increase to 30-50%. Prospective studies have demonstrated that patient [....] » Read More

Tahmineh Azizi, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Tahmineh Azizi, University of Wisconsin, United States

In this study, we explore the possibility that ECG recordings belong to class of multifractal process for which a large number of scaling exponents are required to characterize their scaling structures. We use the BIDMC Congestive Heart Failure database including long term ECG re [....] » Read More

Ayisha Zaka Bashir, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Ayisha Zaka Bashir, Children’s Hospital and Medical Center, United States

Peripheral artery disease (PAD) is a cardiovascular disease affecting more than 8.5 million Americans over the age of 40 years and is prevalent in the geriatric cardiology population. PAD is a manifestation of systemic atherosclerosis, characterized by atherosclerotic blockages o [....] » Read More

James V Cireddu , Speaker at Heart Conferences
Oral Presentation (Virtual)
James V Cireddu , Case Western University, United States

Telehealth is a growing field of importance, but the loss of comprehensive physical exam data creates barriers to managing complex heart failure patients.  Innovative digital tools such as VPExam Virtual Care combine augmented reality guidance of video acquisitions with Blue [....] » Read More

Iris Panagiota Efthymiou, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Iris Panagiota Efthymiou, University of East London, United Kingdom

The pursuit of cardiovascular wellness is of paramount global concern, touching the lives of many individuals and societies. Understanding the intricate interplay between economics and behavior in the context of heart health is pivotal for crafting effective strategies to mitigat [....] » Read More

Eesha Wahid, Speaker at Heart Conferences
Oral Presentation (Virtual)
Eesha Wahid, Trinity College Dublin, Ireland

Increased physiological demands coupled with haemodynamic changes occurring during pregnancy pose a unique and significant challenge to the cardiovascular system.  Pregnant women are at risk of suffering from the exacerbation of pre-existing cardiovascular disease (CVD) as w [....] » Read More

Paraskevi Theofilou, Speaker at Heart Conferences
Oral Presentation (Virtual)
Paraskevi Theofilou, General Hospital of Thoracic Diseases Sotiria, Greece

Exercise is an important factor of rehabilitation in heart failure patients, improving several indicators of disease prognosis and functional capacity. The aim of the present study was to examine the effect of a cardiorespiratory rehabilitation program on the physical and mental [....] » Read More

Helen Senderovich, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Helen Senderovich, Baycrest Health Sciences, Canada

Introduction: Congestive heart failure (CHF) is an increasingly prevalent terminal illness in a globally aging population. Despite optimal medical management, prognosis remains poor – a fact seldom communicated to patients and/or their families.  Evidence suggests [....] » Read More

 Maria Borrell, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Maria Borrell, Sant Pau Institute for Biomedical Research, Spain

Atherosclerosis, the leading cause of cardiovascular diseases, is driven by high blood cholesterol levels and chronic inflammation. The disruption of the hepatic interaction between Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) and Low-Density Lipoprotein Receptor (LDLR) downr [....] » Read More

Xueying Tian, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Xueying Tian, Fudan University, China

Neovascularization of the ischemic myocardium following infarction is vital for the survival of cardiomyocytes and prevention of heart failure. However, the intrinsic revascularization following ischemic injury in the heart is inadequate to restore blood flow to the infarcted myo [....] » Read More

Samir Morcos Rafla, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Samir Morcos Rafla, Alexandria University, Egypt

Most palpitations in pregnancy are benign and usually occur due to atrial or ventricular premature complexes. Careful consideration should be given to the gestation stage and the patient's hemodynamic state. In hemodynamically stable pregnant patients with acute onset of [....] » Read More

Yasser Mohammed Hassanain Elsayed, Speaker at Heart Conferences
Oral Presentation (Virtual)
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt

Background: Arrhythmias are one of the most serious disorders in cardiovascular and clinical medicine. Understanding the pathogenesis and mechanisms of arrhythmias is very advantageous to the appropriate management and treatment of all arrhythmia types. The “Graded phenomen [....] » Read More

Yeganeh Mobasser, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Yeganeh Mobasser, MUMS, Iran (Islamic Republic of)

Background: Cigarette smoking and hypertension are, respectively, the first and second leading causes of preventable mortality worldwide. Smoking can raise blood pressure and accelerate atherothrombotic processes through a variety of potential mechanisms, including deleterious ef [....] » Read More

Vikram Jitendra, Speaker at Heart Conferences
Oral Presentation (Virtual)
Vikram Jitendra, Aberdeen Royal Infirmary, United Kingdom

Aortic stenosis is the most common valvular disease and has a poor prognosis without surgical treatment. The use of sutureless valves (SV) has been emerging as a promising surgical option in certain patient populations especially in the elderly, frail and in redo cardiac procedur [....] » Read More

Zuowei Pei, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Zuowei Pei, Central Hospital Of Dalian University Of Technology, China

Hypertensive?HTN? is one of the risk factors for cardiovascular disease, and exercise has a protective effect on the heart. However, the mechanism by which exercise affects HTN-induced myocardial damage is unclear. In this study, the exercise response model of HTN myocardial inju [....] » Read More

Marina A Chichkova, Speaker at Heart Conferences
Oral Presentation (Virtual)
Marina A Chichkova, Federal State Budgetary Institution, Russian Federation

A new coronavirus infection identified by the World Health Organization Committee as COVID-19 ("Coronavirus disease 2019") with the official name of the causative agent of infection – SARS-CoV-2. Some patients develop hypercoagulation syndrome with thrombosis [....] » Read More

Aryan Gajjar, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Aryan Gajjar, University of California, United States

When Should Patients with Atrial Fibrillation Start Anticoagulation following an Acute Ischemic Stroke?  Background: As the cornerstone of secondary stroke prevention, patients with acute ischemic stroke (AIS) in the presence of atrial fibrillation (Afib) must begin or co [....] » Read More

Joao Rafael Rocha Da Silva, Speaker at Heart Conferences
Oral Presentation (Virtual)
Joao Rafael Rocha Da Silva, Connect Life Rehabilitation And Performance, Brazil

Chronic pain is defined as persistent pain for more than three months and can be classified as primary with no known etiology, or secondary pertinent to a pathological process and specific clinical diagnosis.In previous studies, we observed that it directly impacts cardiac rehabi [....] » Read More

Mengyi Liu, Speaker at Heart Conferences
Oral Presentation (Virtual)
Mengyi Liu, Chinese Academy of Medical Sciences, China

Background: Acute kidney injury (AKI) is a common complication following coronary artery bypass grafting (CABG) surgery, with an incidence of 30-60%, significantly impacting both short-term and long-term mortality. In patients undergoing CABG, severe multivessel coronary art [....] » Read More

Mengyi Liu, Speaker at Heart Conferences
Oral Presentation (Virtual)
Mengyi Liu, Chinese Academy of Medical Sciences, China

Background: Postoperative atrial fibrillation (POAF) is the most common complication following coronary artery bypass grafting (CABG), which increases the risk of stroke and mortality, prolongs the length of hospital stays, and leads to higher healthcare costs. Structural ch [....] » Read More

 Zhongchen Li, Speaker at Heart Conference
Oral Presentation (Virtual)
Zhongchen Li, Fuwai Hospital, CAMS and PUMC, China

Background: The triglyceride-glucose (TyG) index, which is a reliable substitute indicator for insulin resistance, has been considered an independent risk factor for long-term outcomes in patients with cardiovascular disease. However, at present, only a limited number of stu [....] » Read More

Marc Bisnaire, Speaker at Heart Conferences
Oral Presentation (Virtual)
Marc Bisnaire, Cardio Phoenix Ltd, United Kingdom

Dyspnea, characterized by abnormal or uncomfortable breathing, is a common symptom encountered in primary care and often indicates underlying cardiac or pulmonary conditions. However, the diagnostic pathway for dyspnea patients is often convoluted, involving multiple referrals [....] » Read More

 Zhongchen Li, Speaker at Heart Conference
Oral Presentation (Virtual)
Zhongchen Li, Fuwai Hospital, CAMS and PUMC, China

Background: Lipoprotein(a) has been implicated as a pathogenic risk factor for atherosclerosis and its complications. The triglyceride-glucose (TyG) index, a novel surrogate marker for insulin resistance (IR), has been identified as an independent predictor of adverse cardia [....] » Read More

Grace Qiu, Speaker at Heart Conferences
Poster Presentation (Virtual)
Grace Qiu, Thomas Jefferson University, United States

Background: It is well known that conventional right ventricular (RV) pacing results in left ventricular dyssynchrony. Approximately 30% of patients with normal baseline ejection fraction (EF) and >40% of RV pacing will go on to develop cardiomyopathy and heart failure. Conduc [....] » Read More

Dae Wook Lee, Speaker at Cardiovascular Conference
Poster Presentation (Virtual)
Dae Wook Lee, Novartis Pharmaceuticals, Korea, Republic of

In the rapidly evolving landscape of healthcare, the role of Medical Affairs (MA) is increasingly pivotal in the successful launch of new molecular entities (NMEs). This abstract delves into the innovative approaches that are revolutionizing MA, specifically focusing on how these [....] » Read More

Shenghan Zhong, Speaker at Heart Conferences
Poster Presentation (Virtual)
Shenghan Zhong, Chongqing Kanghua Zhonglian Cardiovascular Hospital, China

Background: This study aims to evaluate the efficacy, safety, and long-term effects of sacubitril/valsartan in treating hypertrophic cardiomyopathy using a hypertrophic cardiomyopathy rat model and in vitro cardiomyocytes. Hypertrophic cardiomyopathy presents a challenge in cardi [....] » Read More

Watsapp